Early Aubagio ‘preferable for preventing disease progression’
Early Aubagio reduces disability progression more significantly than delayed treatment in patients with multiple sclerosis (MS), according to results from the phase three TOWER study and its open-label extension phase, presented at the 2015 Annual Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)... Read more - http://www.ms-uk.org/MSnews
Early Aubagio ‘preferable for preventing disease progression
Early Aubagio ‘preferable for preventing disease progression
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2758 Views
-
Last post by NHE
-
- 0 Replies
- 1298 Views
-
Last post by frodo
-
- 0 Replies
- 1333 Views
-
Last post by NHE
-
- 0 Replies
- 1366 Views
-
Last post by frodo
-
- 0 Replies
- 1525 Views
-
Last post by NHE
-
- 0 Replies
- 1241 Views
-
Last post by frodo
-
- 0 Replies
- 1605 Views
-
Last post by NHE
-
- 0 Replies
- 2003 Views
-
Last post by DIM
-
- 0 Replies
- 1846 Views
-
Last post by seeva